These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 35246173)
1. Increased risk of internal tumors in DNA repair-deficient xeroderma pigmentosum patients: analysis of four international cohorts. Nikolaev S; Yurchenko AA; Sarasin A Orphanet J Rare Dis; 2022 Mar; 17(1):104. PubMed ID: 35246173 [TBL] [Abstract][Full Text] [Related]
2. The French Cohort of DNA Repair-Deficient Xeroderma Pigmentosum Patients: Risk of Hematological Malignancies. Sarasin A Cancers (Basel); 2023 May; 15(10):. PubMed ID: 37345043 [TBL] [Abstract][Full Text] [Related]
3. A prevalent mutation with founder effect in xeroderma pigmentosum group C from north Africa. Soufir N; Ged C; Bourillon A; Austerlitz F; Chemin C; Stary A; Armier J; Pham D; Khadir K; Roume J; Hadj-Rabia S; Bouadjar B; Taieb A; de Verneuil H; Benchiki H; Grandchamp B; Sarasin A J Invest Dermatol; 2010 Jun; 130(6):1537-42. PubMed ID: 20054342 [TBL] [Abstract][Full Text] [Related]
4. A new XPC gene splicing mutation has lead to the highest worldwide prevalence of xeroderma pigmentosum in black Mahori patients. Cartault F; Nava C; Malbrunot AC; Munier P; Hebert JC; N'guyen P; Djeridi N; Pariaud P; Pariaud J; Dupuy A; Austerlitz F; Sarasin A DNA Repair (Amst); 2011 Jun; 10(6):577-85. PubMed ID: 21482201 [TBL] [Abstract][Full Text] [Related]
5. Association between DNA repair-deficiency and high level of p53 mutations in melanoma of Xeroderma pigmentosum. Spatz A; Giglia-Mari G; Benhamou S; Sarasin A Cancer Res; 2001 Mar; 61(6):2480-6. PubMed ID: 11289118 [TBL] [Abstract][Full Text] [Related]
8. Clinical and genetic characteristics of xeroderma pigmentosum in Nepal. Espi P; Parajuli S; Benfodda M; Lebre AS; Paudel U; Grange A; Grybek V; Grange T; Soufir N; Grange F J Eur Acad Dermatol Venereol; 2018 May; 32(5):832-839. PubMed ID: 29178624 [TBL] [Abstract][Full Text] [Related]
9. Early-onset gynecological tumors in DNA repair-deficient xeroderma pigmentosum group C patients: a case series. Yurchenko AA; Fresneau B; Borghese B; Rajabi F; Tata Z; Genestie C; Sarasin A; Nikolaev SI Commun Med (Lond); 2023 Aug; 3(1):109. PubMed ID: 37567969 [TBL] [Abstract][Full Text] [Related]
10. DNA repair protects against cutaneous and internal neoplasia: evidence from xeroderma pigmentosum. Kraemer KH; Lee MM; Scotto J Carcinogenesis; 1984 Apr; 5(4):511-4. PubMed ID: 6705149 [TBL] [Abstract][Full Text] [Related]
11. Spotlight on 'xeroderma pigmentosum'. Fassihi H Photochem Photobiol Sci; 2013 Jan; 12(1):78-84. PubMed ID: 23132518 [TBL] [Abstract][Full Text] [Related]
12. The role of sunlight and DNA repair in melanoma and nonmelanoma skin cancer. The xeroderma pigmentosum paradigm. Kraemer KH; Lee MM; Andrews AD; Lambert WC Arch Dermatol; 1994 Aug; 130(8):1018-21. PubMed ID: 8053698 [TBL] [Abstract][Full Text] [Related]
13. [Xeroderma pigmentosum. A study in 40 Algerian patients]. Bouadjar B; Aït-Belkacem F; Daya-Grosjean L; Sarasin A; Larbaoui SL; Ferhat R; Cherid MC; Bendissari A; Chouiter A; Bouzid K; Henni T; Hafiz A; Allouache A; Ysmail-Dahlouk M Ann Dermatol Venereol; 1996; 123(5):303-6. PubMed ID: 8761081 [TBL] [Abstract][Full Text] [Related]
14. Clinical and molecular epidemiological study of xeroderma pigmentosum in China: A case series of 19 patients. Zhou EY; Wang H; Lin Z; Xu G; Ma Z; Zhao J; Feng C; Duo L; Yin J; Yang Y J Dermatol; 2017 Jan; 44(1):71-75. PubMed ID: 27607234 [TBL] [Abstract][Full Text] [Related]
15. Complementation of the DNA repair deficiency in human xeroderma pigmentosum group a and C cells by recombinant adenovirus-mediated gene transfer. Muotri AR; Marchetto MC; Zerbini LF; Libermann TA; Ventura AM; Sarasin A; Menck CF Hum Gene Ther; 2002 Oct; 13(15):1833-44. PubMed ID: 12396616 [TBL] [Abstract][Full Text] [Related]
16. Carrier frequency of the recurrent mutation c.1643_1644delTG in the XPC gene and birth prevalence of the xeroderma pigmentosum in Morocco. Doubaj Y; Laarabi FZ; Elalaoui SC; Barkat A; Sefiani A J Dermatol; 2012 Apr; 39(4):382-4. PubMed ID: 22211393 [TBL] [Abstract][Full Text] [Related]
17. XPC deficiency increases risk of hematologic malignancies through mutator phenotype and characteristic mutational signature. Yurchenko AA; Padioleau I; Matkarimov BT; Soulier J; Sarasin A; Nikolaev S Nat Commun; 2020 Nov; 11(1):5834. PubMed ID: 33203900 [TBL] [Abstract][Full Text] [Related]
18. Genetic correction of DNA repair-deficient/cancer-prone xeroderma pigmentosum group C keratinocytes. Arnaudeau-Bégard C; Brellier F; Chevallier-Lagente O; Hoeijmakers J; Bernerd F; Sarasin A; Magnaldo T Hum Gene Ther; 2003 Jul; 14(10):983-96. PubMed ID: 12869216 [TBL] [Abstract][Full Text] [Related]
19. p53 mutations in skin and internal tumors of xeroderma pigmentosum patients belonging to the complementation group C. Giglia G; Dumaz N; Drougard C; Avril MF; Daya-Grosjean L; Sarasin A Cancer Res; 1998 Oct; 58(19):4402-9. PubMed ID: 9766670 [TBL] [Abstract][Full Text] [Related]
20. Diagnosis of Xeroderma Pigmentosum Groups A and C by Detection of Two Prevalent Mutations in West Algerian Population: A Rapid Genotyping Tool for the Frequent XPC Mutation c.1643_1644delTG. Bensenouci S; Louhibi L; De Verneuil H; Mahmoudi K; Saidi-Mehtar N Biomed Res Int; 2016; 2016():2180946. PubMed ID: 27413738 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]